<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02514980</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00008718/ ref. no.103</org_study_id>
    <nct_id>NCT02514980</nct_id>
  </id_info>
  <brief_title>Infra-orbital Nerve Block for Post Operative Analgesia in Children Undergoing Cleft Lip Surgery.</brief_title>
  <acronym>IFONB</acronym>
  <official_title>Infra-orbital Nerve Block for Post Operative Analgesia in Young Children Undergoing Pediatric Cleft Lip Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study will be undertaken to evaluate the safety and analgesic efficacy of adding
      ketamine to bupivacaine in bilateral infra-orbital nerve block for relief of pain
      postoperatively following repair of cleft lip in children less than two years of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oro-facial clefts are the most prevalent craniofacial birth defects and the second most
      common birth anomaly, second only to clubfoot [Strong &amp; Buckmiller 2001]. Cleft lip surgery
      is associated with appreciable postoperative pain in children Alleviation of postoperative
      pain is important in these patients. The fear of respiratory depression using opioids has
      renewed the interest in regional anesthesia to provide safe and effective postoperative
      analgesia. Infra-orbital nerve block has been advocated as a suitable local analgesic
      technique for cleft lip surgery and superficial surgery on the mid face [Morton 2004, Takmaz
      et al. 2009, Rajesh et al. 2011, Jindal et al. 2011].The infra-orbital nerve supplies the
      upper lip, lower eyelid, and adjacent skin of the cheek and nose. Unilateral or bilateral
      infra-orbital nerve block has been performed with a very high success rate.

      The investigators designed this study to evaluate the safety and analgesic efficacy of adding
      ketamine to bupivacaine in bilateral infra-orbital nerve block for relief of pain
      postoperatively following repair of cleft lip in children less than two years of age.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative analgesic consumption</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>the total consumption of analgesics in the first 24h postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative The Face, Legs, Activity, Cry, Consolability ( FLACC) pain score</measure>
    <time_frame>24 h postoperative.</time_frame>
    <description>FLACC pain score will be recorded on arrival to the recovery room (0) and at 1, 2, 3, 4, 8, 12, and 24 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parent satisfaction score</measure>
    <time_frame>24 h postoperative</time_frame>
    <description>The parents will be asked to evaluate their satisfaction regarding pain control at the end of 24 hours over a score of 4 points (1=bad, 2=moderate, 3=good, 4=excellent).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Bupivacaine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infraorbital nerve block using bupivacaine 0.25% on each side.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine-Ketamine group.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infraorbital nerve block using bupivacaine 0.25% combined with 0.5mg/kg ketamine on each side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Infraorbital nerve block using bupivacaine 0.25% on each side.</description>
    <arm_group_label>Bupivacaine group</arm_group_label>
    <arm_group_label>Bupivacaine-Ketamine group.</arm_group_label>
    <other_name>bucaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Infraorbital nerve block using 0.5mg/kg ketamine on each side.</description>
    <arm_group_label>Bupivacaine-Ketamine group.</arm_group_label>
    <other_name>Katalar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        (ASA) physical status I and II aged less than 2 years undergoing elective cleft lip repair
        (with or without cleft palate) under general anesthesia.

        Exclusion Criteria:

        Patients with local infection at the site of injection of block, history suggestive of drug
        allergy, any systemic disease that compromises the cardiovascular, respiratory or
        neurological function, other congenital anomaly, history of upper or lower airway disease,
        coagulation disorders, and children with history of sleep apnea and in whom postoperative
        ventilation may be required will be excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hala S Abdel-Ghaffar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assisstant professor in Anesthesia and intensive care department, faculty of medicine, Assiut university, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assiut university hospitals</name>
      <address>
        <city>Assiut</city>
        <state>Assiut governorate</state>
        <zip>715715</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2015</study_first_posted>
  <last_update_submitted>January 28, 2017</last_update_submitted>
  <last_update_submitted_qc>January 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Hala Saad Abdel-Ghaffar</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Cleft Lip</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>This is a single center study with no plan to share data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

